NEWARK, Calif., July 31, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it… […]
REDWOOD CITY, Calif., July 31, 2019 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today announced that Steve Basta, M… […]
Every year, hydraulic fracturing of oil and gas wells generates billions of gallons of contaminated water. Scientists at Berkeley Lab and the CO School of Mines believe microbes could be the key to turning this waste into a resource.
The post Can We Re… […]
SOUTH SAN FRANCISCO, Calif., July 31, 2019 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that Gerald McMahon, Ph.D., President and Ch… […]
MENLO PARK, Calif., July 31, 2019 (GLOBE NEWSWIRE) — Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced that Mark McCamish, M… […]